Latest News
Cure SMA Announces New $140,000 Basic Research Grant to Chad Heatwole, MD, at the University of Rochester
Cure SMA has awarded a $140,000 research grant to Chad Heatwole, MD, at the University of Rochester for his project, “Development of a Clinically Relevant Outcome Measure for SMA Therapeutic […]
Read More ›SMA Researcher Meeting to Host Over 100 Presentations
The Annual SMA Conference consists of two separate events that run in parallel. The first is focused on families affected by SMA, who gather for workshops, keynote sessions, networking, and […]
Read More ›Biogen Announces NURTURE, a New Phase 2 Clinical Trial
Biogen, in collaboration with Isis Pharmaceuticals, has announced that they will soon open recruiting for NURTURE. This is a multi-center, Phase 2 clinical study evaluating the efficacy of the investigational […]
Read More ›Newfield Exploration Gives Generous Grant to Cure SMA
On Monday, February 9, 2015, Newfield Exploration presented Cure SMA with a grant for $2,500 to support ongoing research in finding a cure. Accepting the grant on behalf of Cure […]
Read More ›Cure SMA Announces Additional $315,000 for SMA Drug Program at The California Institute of Biomedical Research
Cure SMA is pleased to announce that we have extended our spinal muscular atrophy research program with the California Institute of Biomedical Research (CALIBR) with an additional $315,000 drug discovery […]
Read More ›Cure SMA Releases Updated Overview of Research Model
When Cure SMA first started funding research thirty years ago, we had to build up from virtually nothing. It’s no easy task. Drug development relies on volume to be successful—just […]
Read More ›